Robin Buerki, MD

Address505 Parnassus Avenue
San Francisco CA 94117
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lukas RV, Wu J, Dey M, Buerki RA, Byrne RW, Dohrmann GJ. A Survey of the Neuro-Oncology Landscape. J Clin Neurol. 2017 Oct 31. PMID: 29141278.
      View in: PubMed
    2. Lukas RV, Buerki R, Mrugala MM. Management of Leptomeningeal Disease From Solid Tumors. Oncology (Williston Park). 2016 08; 30(8):724-30. PMID: 27535669.
      View in: PubMed
    3. Brown DP, Jones DC, Anderson KJ, Lapaque N, Buerki RA, Trowsdale J, Allen RL. The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection. BMC Immunol. 2009 Oct 27; 10:56. PMID: 19860908; PMCID: PMC2773765.
    4. de Bruin A, Maiti B, Jakoi L, Timmers C, Buerki R, Leone G. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation. J Biol Chem. 2003 Oct 24; 278(43):42041-9. PMID: 12893818.
      View in: PubMed
    5. Patil KD, Buerki RA, Patil PN. Potentiation of acetylcholine action by huperzine-A and physostigmine on some vertebrate effectors, including human iris sphincter muscle. J Ocul Pharmacol Ther. 2003 Apr; 19(2):135-43. PMID: 12804058.
      View in: PubMed
    Robin's Networks
    Derived automatically from this person's publications.
    Related Authors
    People who share related concepts with this person.
    Back to TOP